We here describe three new ARHGAP26-positive cases with isolated cognitive impairment in two patients and a tumor association in all three cases, suggesting a broader clinical spectrum and highlighting the importance to screen antibody-positive patients for malignancies. Here, ARHGAP26 is linked to neoplasm.